Laboratory techniques

Rockland Develops Antibody Proven to Detect SARS-CoV-2 in Patient Samples

Friday, May 29, 2020 - 7:20pm

Rockland Immunochemicals Inc. has developed a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19 .

Key Points: 
  • Rockland Immunochemicals Inc. has developed a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19 .
  • This antibody has proven effective in lateral flow assays (immunochromatography), ELISA, Western blotting, Immunofluorescence microscopy, fluorescence-activated cell sorting, and immunohistochemistry.
  • Dr. Carl Ascoli, Chief Science Officer for Rockland Immunochemicals Inc. stated that, This antibody is invaluable for the highly accurate detection of SARS-CoV-2 and subsequently COVID-19 disease in various types of patient samples, including nasal and throat swab extracts and saliva.
  • Rockland is currently in large scale production of this antibody for deployment in rapid tests that can be manufactured and distributed widely.

Swift Biosciences Enables COVID-19 Surveillance with NGS of Low Titer SARS-CoV-2 Specimens

Thursday, May 28, 2020 - 2:00pm

Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens.

Key Points: 
  • Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens.
  • The two-round PCR kit supports high throughput processing by converting and enriching viral cDNA into multiplexed, NGS-ready libraries.
  • Following presence/absence assessment using qRT-PCR, excess cDNA was used as input into the Swift SNAP workflow to establish an NGS-based mutation profile for public health surveillance.
  • Swift Biosciences develops and commercializes NGS Library Preparation Kits that enable technologies for genomics, translational, and clinical research.

New Genedata Screener Release Features Advanced Assay Registration and Decision Support for Biopharma R&D

Thursday, May 28, 2020 - 1:30pm

Genedata will host a webinar on June 10, 2020, detailing and demonstrating the features and benefits of the new software release.

Key Points: 
  • Genedata will host a webinar on June 10, 2020, detailing and demonstrating the features and benefits of the new software release.
  • From simple to complex assays, Assay Catalog consistently captures assay biology and experimental conditions and links screening data to them.
  • "Genedata Screener 17.0 represents a major step forward to automating screening workflows," noted Othmar Pfannes, Ph.D., CEO of Genedata.
  • On June 10, 2020, Genedata will host a webinar, "What's New in Genedata Screener 17.0", detailing and demonstrating the new features and benefits of the new software release.

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory

Thursday, May 28, 2020 - 12:55pm

Given the highly contagious nature of this virus, this is a long time to wait.

Key Points: 
  • Given the highly contagious nature of this virus, this is a long time to wait.
  • Until these studies are completed and the FDA grants LexaGenes instrument EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.
  • End-users simply need to collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID and press go.
  • The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Global Molecular Diagnostics Market Analysis, Trends and Forecasts with Profiles of Leading Players Including Abbott Laboratories, bioMrieux SA, Cepheid, Hologic Inc. and Thermo Fischer Scientific Inc.

Wednesday, May 27, 2020 - 3:30pm

DUBLIN, May 27, 2020 /PRNewswire/ -- The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 27, 2020 /PRNewswire/ -- The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry.
  • The PCR market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned.
  • In Japan, the PCR segment will reach a market size of US$200.2 Million by the close of the analysis period.

Quidel to Present Virtually at William Blair 40th Annual Growth Stock Conference

Tuesday, May 26, 2020 - 9:10pm

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 40th Annual Growth Stock Conference to be held virtually on Wednesday, June 10, 2020.

Key Points: 
  • Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the William Blair 40th Annual Growth Stock Conference to be held virtually on Wednesday, June 10, 2020.
  • Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on that day at 10:40 a.m. Central time (8:40 a.m. Pacific time) in a question-and-answer teleconference format.
  • During the presentation, the company will discuss business and financial developments and trends.
  • The company's statements may contain or constitute material information that has not been previously disclosed.

Global Market Trajectory & Analytics for the World Molecular Diagnostics Market: Rising Emphasis on Lab Automation to Augur Well for Market Growth - ResearchAndMarkets.com

Monday, May 25, 2020 - 5:09pm

The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry.
  • The PCR market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned.
  • In Japan, the PCR segment will reach a market size of US$200.2 Million by the close of the analysis period.

SG Blocks Completes U.S. Import Registration for the GeneFinder® COVID-19 Plus RealAmp Kit Produced by OSANG Healthcare

Friday, May 22, 2020 - 5:00pm

The GeneFinder COVID-19 Plus RealAmp Kit test is a polymerase chain reaction (PCR) SARS-CoV-2 test for COVID-19 available in the United States under the FDAs Emergency Use Authorization.

Key Points: 
  • The GeneFinder COVID-19 Plus RealAmp Kit test is a polymerase chain reaction (PCR) SARS-CoV-2 test for COVID-19 available in the United States under the FDAs Emergency Use Authorization.
  • On May 5, 2020, the Company announced the signing of a one-year, non-exclusive distributorship agreement with OHC for its GeneFinder COVID-19 Plus RealAmp Kit in the United States.
  • SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction.
  • Each project starts with GreenSteel, the structural core and shell of an SG Blocks building, and then customized to client specifications.

OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test

Friday, May 22, 2020 - 12:00pm

A product of OraSures DNA Genotek subsidiary, OMNIgeneORAL (OM-505) is an all-in-one collection kit for the detection of DNA and RNA from viruses.

Key Points: 
  • A product of OraSures DNA Genotek subsidiary, OMNIgeneORAL (OM-505) is an all-in-one collection kit for the detection of DNA and RNA from viruses.
  • Earlier this month, the Companys ORAcollectRNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples EUA granted to Biocerna LLC for its PCR-based SARS-CoV-2 assay.
  • P23 Labs was able to leverage the usability studies for our OrageneDx general 510(k) clearance to reduce the time required for submitting their EUA.
  • P23 Labs combine innovation, quality, and creativity with science and information technology to emerge as a leader in molecular testing.

Research Report with COVID-19 Forecasts -Transmission Electron Microscope Market 2020-2024 | Demand of New Forms of Transmission Electron Microscopes to Boost Growth | Technavio

Friday, May 22, 2020 - 6:30am

Our transmission electron microscope market report covers the following areas:

Key Points: 
  • Our transmission electron microscope market report covers the following areas:
    This study identifies increasing 3D analysis needs from advanced materials to bio-samples as one of the prime reasons driving the transmission electron microscope market growth during the next few years.
  • Transmission Electron Microscope Market 2020-2024: Vendor Analysis
    We provide a detailed analysis of vendors operating in the transmission electron microscope market, including some of the vendors such as Advantest Corp., Carl Zeiss AG, DELONG INSTRUMENTS AS, Hirox Co., Ltd., Hitachi High-Technologies Corp., JEOL Ltd., Nikon Metrology NV, Nion Co., and Thermo Fisher Scientific Inc.
  • Backed with competitive intelligence and benchmarking, our research reports on the transmission electron microscope market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Transmission Electron Microscope Market 2020-2024: Key Highlights